Infections in patients with aplastic anemia: Experience at a tertiary care cancer center

Cancer

Volumn 98, Issue 1, 2003, Pages 86-93

  Torres, Harrys A ^a   Bodey, Gerald P ^a   Rolston, Kenneth V I ^a   Kantarjian, Hagop M ^a   Raad, Issam I ^a   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aplastic anemia; Infection; Invasive fungal infection; Molds; Neutropenia

Indexed keywords

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; CHILD; FEMALE; HUMAN; INFECTION RISK; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC MYCOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOSES; NEUTROPENIA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037664983     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11478     Document Type: Article

References (43)

1. Tichelli A, Socie G, Henry-Amar M, et al. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Ann Intern Med. 1999;130:193-201.
2. Storb R. Aplastic anemia. J Intraven Nurs. 1997;20:317-322.
3. Weinberger M, Elattar I, Marshall D, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore). 1992;71:24-43.
4. Marmont AM, Bacigalupo A, Van Lint MT, et al. Treatment of severe aplastic anemia with sequential immunosuppression. Exp Hematol. 1983;11:856-865.
5. Gurman G, Celebi H, Ustun C, et al. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia. Ther Apher. 2001;5:54-57.
6. Young NS, Barrett AJ. The treatment of severe acquired aplastic anemia. Blood. 1995;85:3367-3377.
7. Kojima S, Nakao S, Tomonaga M, et al. Consensus conference on the treatment of aplastic anemia. Int J Hematol. 2000;72:118-123.
8. Young N, Griffith P, Brittain E, et al. A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood. 1988;72:1861-1869.
9. Camitta BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood. 1979;53:504-514.
10. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000;96:2049-2054.
11. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
12. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328-340.
13. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
14. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14.
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
16. Scott JL, Cartwright GE, Wintrobe MM. Acquired aplastic anemia: an analysis of thirty-nine cases and review of the pertinent literature. Medicine. 1959;38:119-172.
17. Vincent PC, deGruchy GC. Complications and treatment of acquired aplastic anemia. Br J Haematol. 1967;13:977-999.
18. Twomey JJ, Douglass CC, Sharkey O Jr. The monocytopenia of aplastic anemia. Blood. 1973;41:187-195.
19. Doney KC, Weiden PL, Buckner CD, Storb R, Thomas ED. Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrow. Exp Hematol. 1981;9:829-834.
20. Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 1994;84:941-949.
21. Keidan AI, Tsatalas C, Cohen J, Cousins S, Gordon-Smith EC. Infective complications of aplastic anaemia. Br J Haematol. 1986;63:503-508.
22. Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991;324:1297-1304.
23. Killick SB, Marsh JC. Aplastic anaemia: management. Blood Rev. 2000;14:157-171.
24. Ljungman P. Supportive treatment of patient with severe aplastic anemia. In: Schrezenmeier H, Bacigalupo A, editors. Aplastic anemia: pathophysiology and treatment. Cambridge, UK: Cambridge University Press, 2000:137.
25. Meidlinger P, Knobl P, Jager U, et al. Granulocyte colonystimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment. Ann Hematol. 1999;78:299-304.
26. Bacigalupo A, Broccia G, Corda G, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood. 1995;85:1348-1353.
27. Kojima S. Use of granulocyte colony-stimulating factor for treatment of aplastic anemia. Nagoya J Med Sci. 1999;62:77-82.
28. Rolston KV. Expanding the options for risk-based therapy in febrile neutropenia. Diagn Microbiol Infect Dis. 1998;31:411-416.
29. Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000;31:705-711.
30. Antoniadou A, Torres HA, Lewis RE, et al. In vitro susceptibility and resistance of bloodstream Candida species in a tertiary care cancer center: correlation with outcome of antifungal therapy [abstract M1499]. In: Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; San Diego, CA; September 27-30, 2002. Herndon, VA: American Society for Microbiology Press, 2002.
31. Walsh TJ, Melcher GP, Rinaldi MG, et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol. 1990;28:1616-1622.
32. Torres HA, Kontoyiannis DP. Hyalohyphomycosis (other than Aspergillosis and Penicilliosis). In: Dismukes W, Pappas P, Sobel J, editors. Oxford textbook of clinical mycology. New York: Oxford University Press. 2003:252-270.
33. Girmenia C, Iori AP, Boecklin F, et al. Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica. 1999;84:114-118.
34. Munoz FM, Demmler GJ, Travis WR, et al. Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia. J Clin Microbiol. 1997;35:499-503.
35. Mirkin LD. Alternaria alternata infection of skin in a 6-year-old boy with aplastic anemia. Pediatr Pathol. 1994;14:757-761.
36. Van Steenweghen S, Maertens J, Boogaerts M, Deneffe G, Verbeken E, Nackaerts K. Mucormycosis, a threatening opportunistic mycotic infection. Acta Clin Belg. 1999;54:99-102.
37. Fox BC, Ross DD, Huang AB, Gabrielson EW, Furth PA. Mycobacterial disease associated with aplastic anaemia. J Infect. 1989;19:157-165.
38. Schliep TC, Yarrish RL. Pneumocystis carinii pneumonia. Semin Respir Infect. 1999;14:333-343.
39. Torres HA, Reddy BT, Raad II, et al. Nocardiosis in cancer patients. Medicine (Baltimore). 2002;81:388-397.
40. Barth PJ, Rossberg C, Koch S, Ramaswamy A. Pulmonary aspergillosis in an unselected autopsy series. Pathol Res Pract. 2000;196:73-80.
41. Saah D, Drakos PE, Elidan J, Braverman I, Or R, Nagler A. Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation. Ann Otol Rhinol Laryngol. 1994; 103:306-310.
42. Rodriguez DL, Lopez CA, Cobos EB, Blanco AJ, Fernandez AF, Araujo LF. Invasive cerebral aspergillosis in a patient with aplastic anemia. Response to liposomal amphotericin and surgery. Haematologica. 1999;84:758-759.
43. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis. 1988;10(Suppl 3):S460-S467.